Solid tumours: CAR-T therapies’ Waterloo
Overcoming current limitations and expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.
Drug Manufacturers
Genentech to onshore US manufacturing amid rising drug pricing tensions
Can pharma tariffs “Make America Manufacture Again”?
Revamping US pharma manufacturing: Trump’s executive order faces industry doubts
Roche plans $700m manufacturing plant in the US
Thermo Fisher counters tariffs with $2bn investment into US manufacturing
3 reasons why biotechs preparing for launch need a compliant content foundation
Novartis commits $23bn to US manufacturing amid tariff threats
